… studies, antiviral resistance, clinical trials, safety, and drug tolerability of molnupiravir are
also … to expand our knowledge on molnupiravir and better deal with the COVID-19 epidemic. …

… syndrome coronavirus 2 (SARS-CoV-2). We report the results of a Phase 2a trial evaluating
the safety, tolerability, and antiviral efficacy of molnupiravir in the treatment of COVID-19 (…

… evidence of in vitro and in vivo antiviral activities of molnupiravir and its active form against
highly … for COVID-19, and finding out the efficacy and safety of molnupiravir in clinical trials. …

… Molnupiravir is an antiviral drug with anti-RNA polymerase … literature for the mechanism of
action, safety, efficacy, and clinical trials of molnupiravir in the treatment of COVID-19 patients. …

… Molnupiravir is a newer oral antiviral drug that has recently been tested in COVID-19. We
aim to … of literature to find out the efficacy and safety of molnupiravir in patients with COVID-19. …

… that Molnupiravir possesses promising antiviral activity as … of action of Molnupiravir and
highlights its clinical utility by disabling SARS-CoV-2 replication, thereby ameliorating COVID-19 …

… virus may result in a countermeasure for multiple RNA viruses, which is what we experienced
with molnupiravir and what led to its rapid development for the treatment of COVID-19. …

… widely-used coronavirus treatments. To estimate its antiviral efficacy of Molnupiravir, we built
… We find that the antiviral efficacy of Molnupiravir to stop the growth of the virus is 0.56 (95% …

… of molnupiravir safety and anti-viral activity is presented. Also, the review highlights a
comparison between the current anti-viral agents listed to treat mild to moderate COVID-19 patients …

… New treatments are needed to reduce the risk of progression of coronavirus disease 2019
(Covid-19). Molnupiravir is an oral, small-molecule antiviral prodrug that is active against …